Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Roanoke, VA
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kirkland, WA
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sun City, AZ
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sun City, AZ
Click here to add this to my saved trials
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Albany, NY
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated:  12/31/1969
mi
from
Innsbruck,
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated: 12/31/1969
mi
from
Innsbruck,
Click here to add this to my saved trials
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
West Bloomfield, MI
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Status: Enrolling
Updated:  12/31/1969
University of Alberta Canada
mi
from
Edmonton,
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
Status: Enrolling
Updated: 12/31/1969
University of Alberta Canada
mi
from
Edmonton,
Click here to add this to my saved trials
The Effects of a High Intensity Exercise Training Program in Patients With Parkinson's Disease
The Effects of a High Intensity Exercise Training Program on Sleep and Vigilance in Patients With Parkinson's Disease (The Effect of Low Frequency STN DBS on Sleep and Vigilance in PD Patients)
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
The Effects of a High Intensity Exercise Training Program in Patients With Parkinson's Disease
The Effects of a High Intensity Exercise Training Program on Sleep and Vigilance in Patients With Parkinson's Disease (The Effect of Low Frequency STN DBS on Sleep and Vigilance in PD Patients)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Phoenix, AZ
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Sun City, AZ
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Sun City, AZ
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Fountain Valley, CA
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Los Angeles, CA
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Oxnard, CA
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Oxnard, CA
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Torrance, CA
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Torrance, CA
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Englewood, CO
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Englewood, CO
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Danbury, CT
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Danbury, CT
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Boca Raton, FL
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Port Charlotte, FL
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Tampa, FL
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Atlanta, GA
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Augusta, GA
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Des Moines, IA
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Des Moines, IA
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Kansas City, KA
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Kansas City, KA
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Boston, MA
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Boston, MA
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
West Bloomfield, MI
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Albany, NY
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Albany, NY
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
New York, NY
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
New York, NY
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Asheville, NC
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Durham, NC
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Durham, NC
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Toledo, OH
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Toledo, OH
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Calgary,
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Calgary,
Click here to add this to my saved trials
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
Kyowa PD Site
mi
from
Tucson, AZ
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
A Phase 3, Long-term, Open-label Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Kyowa PD Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease
Pilot Phase I Study of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease
Pilot Phase I Study of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
University of Alabama /ID# 144422
mi
from
Birmingham, AL
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
University of Alabama /ID# 144422
mi
from
Birmingham, AL
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
Parkinson's Disease and Moveme /ID# 144413
mi
from
Boca Raton, FL
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
Parkinson's Disease and Moveme /ID# 144413
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
University of Florida /ID# 144415
mi
from
Gainesville, FL
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
University of Florida /ID# 144415
mi
from
Gainesville, FL
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
University of Miami /ID# 144420
mi
from
Miami, FL
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
University of Miami /ID# 144420
mi
from
Miami, FL
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
Georgia Regents University /ID# 144417
mi
from
Augusta, GA
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
Georgia Regents University /ID# 144417
mi
from
Augusta, GA
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
University of Kentucky Chandler Medical Center /ID# 144421
mi
from
Lexington, KY
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
University of Kentucky Chandler Medical Center /ID# 144421
mi
from
Lexington, KY
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University /ID# 144416
mi
from
Baltimore, MD
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University /ID# 144416
mi
from
Baltimore, MD
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
Mercy St. Mary's Health Center /ID# 144418
mi
from
Grand Rapids, MI
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
Mercy St. Mary's Health Center /ID# 144418
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
University of Kansas Health Sy /ID# 154242
mi
from
Kansas City, MO
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
University of Kansas Health Sy /ID# 154242
mi
from
Kansas City, MO
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine /ID# 147235
mi
from
Saint Louis, MO
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine /ID# 147235
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
Jared Neuroscience Center /ID# 161629
mi
from
Springfield, MO
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
Jared Neuroscience Center /ID# 161629
mi
from
Springfield, MO
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
University of Nebraska Medical Center /ID# 147655
mi
from
Omaha, NE
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
University of Nebraska Medical Center /ID# 147655
mi
from
Omaha, NE
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
Wake Forest Univ HS /ID# 144419
mi
from
Winston-Salem, NC
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
Wake Forest Univ HS /ID# 144419
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated:  12/31/1969
Penn State Child Hosp.Hersh,PA /ID# 160671
mi
from
Hershey, PA
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)
Status: Enrolling
Updated: 12/31/1969
Penn State Child Hosp.Hersh,PA /ID# 160671
mi
from
Hershey, PA
Click here to add this to my saved trials